Search

everythinglearnresearchcommunity

for

Search:↓

A woman's progressive hair loss was correctly diagnosed as a rare condition called fibrosing alopecia in a pattern distribution after initially being mistaken for a more common type.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Lactate is vital for skin health, influencing metabolism, the skin barrier, immune responses, and has therapeutic potential for skin disorders.

Microthermal wounds heal with less scarring due to delayed collagen production and minimal inflammation.

A new treatment using gold nanoclusters can safely reduce unwanted hair growth.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

Targeted immunotherapies may offer better treatment for alopecia areata by controlling inflammation and immune responses.

Laminin 332 is essential for normal skin cell behavior and structure.

New insights into skin damage from UV exposure suggest potential treatments, including targeting specific RNAs and combining therapies for better outcomes.

People with alopecia areata are more likely to have other immune-related conditions.

Improving skin barrier function is crucial for better acne treatment.

Glycyrrhetinic acid from licorice may help treat acne by reducing inflammation and oil production.

Alopecia areata is complex, with genetic and immune factors, and animal models are key for future treatment research.

Chitosan–hydroxyapatite biocomposites are promising for tissue engineering due to their safety and ability to support healing.

Perilla seed extract may help prevent hair loss better than some standard treatments.

Wound healing is a complex, multi-phase process involving various cells and activities to repair skin damage.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Clonally expanded CD8+ T cells cause alopecia areata.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

The document explains various skin conditions and their treatments.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.